Relevant bibliographies by topics / Patented drugs

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Patented drugs'

Author: Grafiati
Published: 28 May 2022
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Patented drugs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Patented drugs"

1

Gao, Hua. "Chinese Legislation and Theoretical Basis for Patent Parallel Import: Consideration of Parallel Import of Pharmaceutical Patents During the Pandemic." Scientific and Social Research 6, no. 1 (2024): 71–84. http://dx.doi.org/10.26689/ssr.v6i1.5916.

Full text
Abstract:
The current Chinese Patent Law permits parallel import, but its theoretical basis is disputed. Neither theprinciple of domestic exhaustion of rights nor the principle of international exhaustion of rights can be used as thetheoretical basis to support parallel import. Chinese legislation can set aside the traditional dispute between the principleof exhaustion of rights and the principle of territoriality, support parallel import in principle, and make exceptions in whichparallel import can be prohibited if the parallel importer violates the contract or authorization agreement or conductsunfair
APA, Harvard, Vancouver, ISO, and other styles
2

Muis, Lidya Shery, and Rasta Octara Nanda. "Urgency of bolar provision regulation on patented drugs for access and availability of generic drugs for public health." BIS Humanities and Social Science 2 (May 30, 2025): V225036. https://doi.org/10.31603/bishss.283.

Full text
Abstract:
Limited availability of medicines is a serious problem in fulfilling the public's right to health. The monopoly of patented medicines by patent-holding pharmaceutical companies has resulted in generic pharmaceutical companies not being able to access information about patented medicines even though the patent has expired. This certainly hinders the immediate circulation of generic versions after the patent expires. Generic medicines are important because they are easier to access, more widely available, and cheaper than patented versions of medicines. To overcome this problem, a legal means ca
APA, Harvard, Vancouver, ISO, and other styles
3

Curci, Gionathan, and Massimo Vittori. "Improving Access to Life-Saving Patented Drugs." Journal of World Intellectual Property 7, no. 5 (2005): 739–60. http://dx.doi.org/10.1111/j.1747-1796.2004.tb00227.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fidelino, R. John. "In Pursuit of Distinction: The Method of the Non-Proprietary Name." Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 5, no. 1 (2007): 45–52. http://dx.doi.org/10.1057/palgrave.jgm.4950079.

Full text
Abstract:
This is an update to a paper that appeared in the very first issue of the Journal of Generic Medicines in October 2003. Over the past few years, pharmaceutical manufacturers have started to diversify their portfolios to include generic medicines as a way to maximise their investment in patented drugs. With this dynamic as context, understanding the development and construction of a generic name may be helpful both to the manufacturer of patented drugs who wants to support the perception of distinctiveness among competition, as well as to the generics marketer who wants to leverage the legacy o
APA, Harvard, Vancouver, ISO, and other styles
5

Rozas, Isabel. "Improving antidepressant drugs: update on recently patented compounds." Expert Opinion on Therapeutic Patents 19, no. 6 (2009): 827–45. http://dx.doi.org/10.1517/13543770902932934.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bearz, Alessandra, Sara Cecco, Sara Francescon, Francesco Lo Re, Giuseppe Corona, and Paolo Baldo. "Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer." Recent Patents on Anti-Cancer Drug Discovery 14, no. 3 (2019): 242–57. http://dx.doi.org/10.2174/1574892814666190726124735.

Full text
Abstract:
Background: Lung cancer is the most frequent cause of cancer-related death. In the last decades, the introduction of targeted therapies and more recently, of immunotherapy, has led to significant improvements in different outcomes of this malignant neoplasm. Objective: The present review provides a balanced overview of most recent targeted therapies and immunotherapies patented for the treatment of lung cancer. Methods: An extensive scientific literature and patent databases search were performed to identify peerreviewed studies containing information on recently patented drugs for the treatme
APA, Harvard, Vancouver, ISO, and other styles
7

Kay, M. "India moves closer to regulating prices of patented drugs." BMJ 348, jan30 5 (2014): g1244. http://dx.doi.org/10.1136/bmj.g1244.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ossorio, Pilar N. "Not Taking, Just Borrowing: Government Use of Patented Drugs." American Journal of Bioethics 2, no. 3 (2002): 51–52. http://dx.doi.org/10.1162/152651602760250174.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hurwitz, Mark A. "Bundling Patented Drugs and Medical Services: An Antitrust Analysis." Columbia Law Review 91, no. 5 (1991): 1188. http://dx.doi.org/10.2307/1122848.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Amanda Dwijayanti and Musa Fitri Fatkhiyah. "Analisis Pengetahuan Penggunaan Obat Paten dan Obat Generik di Desa Sukorejo Kecamatan Ulujami Kabupaten Pemalang." OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan 3, no. 1 (2025): 75–92. https://doi.org/10.61132/obat.v3i1.973.

Full text
Abstract:
Patented drugs are a type of drug that has just been discovered and has a certain patent period based on its type. This drug is designed to provide convenience through innovations such as practical packaging, better taste, and syrup that is not bitter due to the use of micro particles. Technologies such as slow-release tablets or sugar coatings also reduce side effects in the stomach, making them safer to use. In addition, this innovation can overcome other obstacles, such as avoiding alcohol solvents that are not in accordance with some religious beliefs. On the other hand, generic drugs stil
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Patented drugs"

1

Figueiredo, Luciano Lima. "A função social das patentes de medicamentos." Universidade Federal da Bahia, 2008. http://www.repositorio.ufba.br/ri/handle/ri/12373.

Full text
Abstract:
248 f.<br>Submitted by Ana Valéria de Jesus Moura (anavaleria_131@hotmail.com) on 2013-07-31T14:26:22Z No. of bitstreams: 1 LUCIANO LIMA FIGUEIREDO.pdf: 1277407 bytes, checksum: 4a9e492e2ca9afe642e59c6fa5a8d6d0 (MD5)<br>Approved for entry into archive by Ana Valéria de Jesus Moura(anavaleria_131@hotmail.com) on 2013-07-31T14:28:27Z (GMT) No. of bitstreams: 1 LUCIANO LIMA FIGUEIREDO.pdf: 1277407 bytes, checksum: 4a9e492e2ca9afe642e59c6fa5a8d6d0 (MD5)<br>Made available in DSpace on 2013-07-31T14:28:27Z (GMT). No. of bitstreams: 1 LUCIANO LIMA FIGUEIREDO.pdf: 1277407 bytes, checksum: 4a9e492e
APA, Harvard, Vancouver, ISO, and other styles
2

Грабовська, О. В. "Економічний аналіз міжнародного та національного ринку фармацевтичної продукції". Master's thesis, Сумський державний університет, 2018. http://essuir.sumdu.edu.ua/handle/123456789/71513.

Full text
Abstract:
Магістерська робота присвячена аналізу глобального та українського ринку фармацевтичної продукції. Вона аналізує поточну ситуацію на ринку, ризики та переваги, основні рушійні сили та основних гравців на ринку. Головна мета цього дослідження — провести аналіз ринку для міжнародної компанії.<br>The master’s thesis focuses on the analysis of the global and Ukrainian market of pharmaceutical products. It examines the current situation on the market, its risks and benefits, the main driving forces and the main players on the market. The main aim of this study is to conduct the market analysis for
APA, Harvard, Vancouver, ISO, and other styles
3

Harnisch, Sandy. "Die Zwangslizenz im südafrikanischen und deutschen Patentrecht : ein Rechtsvergleich unter besonderer Berücksichtigung der Arzneimittelerfindungen /." Berlin : BWV, Berliner Wiss.-Verl, 2006. http://deposit.ddb.de/cgi-bin/dokserv?id=2792408&prov=M&dok_var=1&dok_ext=htm.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

袁慶文. "基於引證網絡的藥品專利價值分析". Thesis, University of Macau, 2018. http://umaclib3.umac.mo/record=b3952162.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

胡元佳. "Pharmaceutical patent valuation based on technology innovation and applications in the industry." Thesis, University of Macau, 2009. http://umaclib3.umac.mo/record=b2150641.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Oliveira, Carlos Fernando Lopes de. "Patentes de fármacos: as tensões existentes entre os interesses da indústria farmacêutica e as necessidades das populações." Universidade Federal da Paraí­ba, 2010. http://tede.biblioteca.ufpb.br:8080/handle/tede/4363.

Full text
Abstract:
Made available in DSpace on 2015-05-07T14:27:05Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 2044681 bytes, checksum: 09d18643545c26dd327be8c0d35cd1d2 (MD5) Previous issue date: 2010-04-27<br>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior<br>It is a study focused on the medicament patent from the analysis of the existing tensions among the pharmaceutical industry and the population necessities regarding medicine access. It is well-known the inner nature of the fundamental rights the condition of its social function. In this context, reasoning regarding the protection limits co
APA, Harvard, Vancouver, ISO, and other styles
7

Rigestam, Björn. "Pharmaceutical patents and generic drugs : When may interim injunctions be issued against an attempt or preparation to offer generic drugs on the market?" Thesis, Internationella Handelshögskolan, Högskolan i Jönköping, IHH, Rättsvetenskap, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-18933.

Full text
Abstract:
Since the implementation of Directive 2004/48 EC on the Enforcement of Intellectual Property Rights in Sweden there is today a possibility for pharmaceutical companies holding a patent to issue interim injunctions against a generic company on the grounds of an attempt or preparation to a pharmaceutical patent infringement. It has been shown that one of the earliest steps in which a generic company may infringe a pharmaceutical patent is to offer the generic drugs onto the market. However, since the implementation of the attempt and preparation rule in the Swedish Patent Act questions have been
APA, Harvard, Vancouver, ISO, and other styles
8

譚偉民. "活血化瘀中成藥處方和製備工藝改進 : 雲南白藥劑型的質量比較分析". HKBU Institutional Repository, 2010. http://repository.hkbu.edu.hk/etd_ra/1132.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Vargas, Chaves Iván Guillermo. "Balances, realidades y perspectivas de las patentes farmacéuticas." Doctoral thesis, Universitat de Barcelona, 2017. http://hdl.handle.net/10803/664063.

Full text
Abstract:
Esta investigación explora la evolución de la patente farmacéutica en España desde su ordenamiento jurídico interno; el régimen aplicable en el Derecho comunitario europeo; y en el comercio internacional. Se realiza, siguiendo esta línea histórica, una aproximación crítica sobre la necesidad de repensar el equilibrio que debe existir entre la exclusividad que otorga la patente a sus titulares, y un acceso a los medicamentos en igualdad de condiciones. La investigación además sustenta, entre otras cuestiones relevantes en el panorama legislativo y jurisprudencial evolutivo, el contexto en el qu
APA, Harvard, Vancouver, ISO, and other styles
10

Chan, Yuen Cheung. "Quality evaluation and anti-chronic glomerulonephritis properties of a patent herbal drug yi-shen-hua-shi granule." HKBU Institutional Repository, 2020. https://repository.hkbu.edu.hk/etd_oa/825.

Full text
Abstract:
Yi-Shen-Hua-Shi (YSHS) granule is a Chinese patent drug for treating chronic glomerulonephritis (CGN). It was marketed in 2009. However, up to now, there is no report about the quality and pharmacological activities of this product. In this work，we evaluated the quality and anti-CGN effects of the drug. To evaluate the quality of the granule, a qualitative and quantitative HPLC-DAD analytical method was developed. For qualitative analysis, HPLC fingerprint of ten batches of YSHS granule was established. The fingerprints were analyzed using similarity evaluation, hierarchical cluster analysis (
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Patented drugs"

1

Corvari, Ronald. Trends in patented drug prices. Patented Medicine Prices Review Board, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Corvari, Ronald. Verification of foreign patented drug prices. Patented Medicine Prices Review Board, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Patented Medicine Prices Review Board Canada. The impact of federal regulation of patented drug prices. The Board, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Milligan, Eric A. A history of the Patented Medicines Prices Review Board: The early years. Canadian Centre for Management Development, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

New York (State). Legislature. Senate. Committee on Corporations, Authorities, and Commissions. In the matter of high cost of patented pharmaceutical prescription medications: Legislative Office Building, Hearing Room B, Albany, New York, May 31, 2000, 10:10 a.m. to 3:25 p.m., Wednesday. Candyco Transcription Service, Inc., 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Office, General Accounting. Prescription drug prices: Analysis of Canada's Patented Medicine Prices Review Board : report to the chairman, Special Committee on Aging, U.S. Senate. The Office, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Network, Canadian HIV/AIDS Legal. Controlling drug costs for people living with HIV/AIDS: Federal regulation of pharmaceutical prices in Canada. Canadian HIV/Aids Legal Network = Réseau juridique canadien VIH/sida, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Office, General Accounting. Prescription drug prices: Official index overstates producer price inflation : report to the Chairman, Special Committee on Aging, U.S. Senate. The Office, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Canada. Patented Medicine Prices Review Board. Annual report 2007. Patented Medicine Prices Review Board, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

House, United States Congress. A bill to amend title 35, United States Code, to provide for compulsory licensing of certain patented inventions relating to health. [United States Government Printing Office], 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Patented drugs"

1

Luo, Yunqing. "Research on Patented Drugs and Compulsory Licensing." In Applied Economics and Policy Studies. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-5359-9_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Raju, K. D. "Patent Linkages and Its Impact on Access to Medicines: Challenges, Opportunities for Developing Countries." In Access to Medicines and Vaccines. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-83114-1_12.

Full text
Abstract:
AbstractLinking patent protection to generics’ regulatory approvals is a heated topic of discussions and a friction point among countries proposing higher protection for patented drugs. Patent linkage has been pushed through bilateral and regional agreements outside of the WTO system. It is widely understood that patent linkage is implemented to delay the market entry of generic medicines. It is argued here that developing countries are not obliged to take up TRIPs plus patent-linkage obligations.A list of approved drugs and their therapeutic equivalence can be published by every country. The
APA, Harvard, Vancouver, ISO, and other styles
3

Mazumdar, Mainak. "The Problem of Availability of Patented Drugs Due to Product Patent and Parallel Trade: A Theoretical Approach." In Performance of Pharmaceutical Companies in India. Physica-Verlag HD, 2012. http://dx.doi.org/10.1007/978-3-7908-2876-4_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gainey, Laurence D. S. "Patent Considerations When Embarking on New Antisense Drug Programs." In Methods in Molecular Biology. Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2010-6_28.

Full text
Abstract:
AbstractThe aim of this chapter is to provide some key information on patents and the patent system to assist someone embarking on the design, development, and commercialization of new antisense drugs.Here I outline certain key topics such as what is a patent? why patent? how do I protect my molecule with a patent? confidentiality, searching for the same or similar molecules in the prior art, data requirements, the patenting timeline and freedom to operate.
APA, Harvard, Vancouver, ISO, and other styles
5

Rathod, Sandeep Kanak. "Patent Oppositions in India." In Access to Medicines and Vaccines. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-83114-1_6.

Full text
Abstract:
AbstractPre-grant and post-grant oppositions filed in India by civil society and generic companies have been instrumental in visibly increasing access of drugs to the public—both in terms of earlier generic entry and also cheaper prices due to such generic competition. This paper looks at the significant pharmaceutical patent oppositions in India during the last 15 years. It focuses on some unique aspects connected to each of these oppositions and tracks how these oppositions helped in securing earlier access to generic drugs. The last part of the paper analyses patent opposition pendency stat
APA, Harvard, Vancouver, ISO, and other styles
6

Roehrs, Robert E. "Patent Considerations." In Ophthalmic Drug Delivery Systems, 2nd ed. Routledge, 2021. http://dx.doi.org/10.4324/9781003113423-27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Borsos, Mark A. "Patent Protection Strategy." In Early Drug Development. Wiley-VCH Verlag GmbH & Co. KGaA, 2018. http://dx.doi.org/10.1002/9783527801756.ch25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dietsch, Peter. "Patents on Drugs — the Wrong Prescription?" In Intellectual Property and Theories of Justice. Palgrave Macmillan UK, 2008. http://dx.doi.org/10.1007/978-0-230-58239-2_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mishra, Brahmeshwar, and Gunjan Vasant Bonde. "Patent Searching." In Computer Aided Pharmaceutics and Drug Delivery. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-5180-9_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Fatma, Homa, Sadaf R. Khan, and Hifzur R. Siddique. "Cancer Drug Patent Disputes." In Intellectual Property Issues in Life Sciences. CRC Press, 2024. http://dx.doi.org/10.1201/9781003405665-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Patented drugs"

1

Mitsumori, Yaeko, and Monirul Azam. "Data Analysis of the Drug Pipeline of Bangladesh: Preparation for the TRIPS-Compliant Product Patent Regime." In 2024 Portland International Conference on Management of Engineering and Technology (PICMET). IEEE, 2024. http://dx.doi.org/10.23919/picmet64035.2024.10653272.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hsueh, Chao-Chih, and Dar-Zen Chen. "R&D Innovation Patterns and Patent Application Strategy of Top-Selling Drugs: Insights from Patentometric." In 20th International Conference on Scientometrics & Informetrics. Institute for Informatics and Automation Problems of NAS RA, 2025. https://doi.org/10.51408/issi2025_026.

Full text
Abstract:
This article discusses the closed or open innovation patterns adopted by top-selling drugs and their patent application strategy throughout the drug lifecycle. The research samples are 151 top-selling drugs that have ever annual revenue of US $1 billion between 2015 to 2021 identified from the PharmaCompass database and their 1,167 patents listed in the FDA Orange Book. 151 top-selling drugs approved in US FDA from 1988 to 2020. When companies apply a new drug application in the USA, the company needs to submit relevant patents that can reasonably defend against generic drug infringement and l
APA, Harvard, Vancouver, ISO, and other styles
3

Cantrel, E., A. Fonteyne, N. Impens, and A. Rahier. "Oxidation of Organic Radioactive Waste by Electrochemical Mediation." In ASME 2001 8th International Conference on Radioactive Waste Management and Environmental Remediation. American Society of Mechanical Engineers, 2001. http://dx.doi.org/10.1115/icem2001-1185.

Full text
Abstract:
Abstract Liquid as well as solid organic radioactive waste can be processed by means of combustion. However, this method presents several well-known drawbacks including the corrosion of the ovens, the production of radioactive ashes and radioactive or toxic volatile products. The electrochemical mediation process is an excellent alternative to combustion, especially when dealing with hazardous materials such as explosives, pesticides, drugs and nuclear organic waste. Nevertheless, using the silver(II) species as electrogenerated mediator, requires to work in concentrated nitric acid media, whi
APA, Harvard, Vancouver, ISO, and other styles
4

Haichen, Zhou, Jorge Gulín-González, and Chen Yunwei. "Application of Molecular Docking Technology in Drug Discovery Based on Bibliometric and Patent Analysis." In 20th International Conference on Scientometrics & Informetrics. Institute for Informatics and Automation Problems of NAS RA, 2025. https://doi.org/10.51408/issi2025_143.

Full text
Abstract:
In the field of molecular modeling, molecular docking (MD) is a method which predicts the preferred orientation of one molecule to a second when bound to each other to form a stable complex. Knowledge of the preferred orientation in turn may be used to predict the strength of association or binding affinity between two molecules using scoring functions. MD is frequently used to predict the binding orientation of small molecule drugs candidates to their protein targets in order to in turn predict the affinity and activity of the small molecules. MD plays an important role in the rational design
APA, Harvard, Vancouver, ISO, and other styles
5

Azeez, Abolaji, Olubukola Yetunde Azeez, and Matthew Ayegboyin. "Breeding Drug Abusers: Patent Medicine Vendors Experiences in Semi-Urban Areas of Ibadan, Nigeria." In 28th iSTEAMS Multidisciplinary Research Conference AIUWA The Gambia. Society for Multidisciplinary and Advanced Research Techniques - Creative Research Publishers, 2021. http://dx.doi.org/10.22624/aims/isteams-2021/v28n2p12.

Full text
Abstract:
Indiscriminate drug use consistently constitutes a public health threat in developing countries including Nigeria. Therefore, the study explored PMVs’ experiences to understand the socio-economic factors accountable for the demand and dispensation of multiple drugs to clients. The study was exploratory and qualitative. Through respondents determined survey (RDS), four patent medicine vendors and one pharmacist were recruited into the study for in-depth interviews. The PMVs had at least 7 years’ experience and were aware of the restrictions guiding drugs they could sell. Although PMVs were proh
APA, Harvard, Vancouver, ISO, and other styles
6

Suryakrishna, S. S., K. Praveen, S. Tamilselvan, and S. Srinath. "IoT Based Automation and Blockchain for Medical Drug Storage and Smart Drug Store." In Intelligent Computing and Technologies Conference. AIJR Publisher, 2021. http://dx.doi.org/10.21467/proceedings.115.8.

Full text
Abstract:
The increase in the work stress and decrease in the time for oneself has led to the rise in the dependency on the medicines and drugs. The drugs and medicines are the key sources for saving the human life when the patient is in the danger. In order to maintain regular and quality supply of the drugs and medicines has to monitor on the regular basis. There are numerous medicines and drugs brought in the store but usually drugs and medicines are stolen to satisfy one’s greed, get expired or placed at unknown locations in the store. So to prevent such situation and saving the life of the patient
APA, Harvard, Vancouver, ISO, and other styles
7

Melnik, R. N. "HISTORY OF CREATION OF THE BIOPREPARATION DRYNG DEPARTAMENT OF THE INSTITUTE FGBNU «VNITIBP»." In БИОТЕХНОЛОГИЯ: НАУЧНЫЕ ИССЛЕДОВАНИЯ И СВЯЗЬ С ПРОИЗВОДСТВОМ. Всероссийский научно-исследовательский и технологический институт биологической промышленности, 2024. https://doi.org/10.47804/978-5-89904-038-2-2024-53-60.

Full text
Abstract:
The article is devoted to the history of creation of the department of drying of biopreparations, shows the formation and development of the department of creation of live vaccines by means of lyophilic drying of live antigens. The article shows the founders of the production of dried veterinary preparations. Gradually freeze-dried biopreparations entered the veterinary practice. In 2000 at Shchelkovsky Biokombinat already 50% of the whole range of vaccines and diagnostic preparations were produced in dry form. Since 1957 the freeze drying shop was equipped with “Leibold” type units from GDR,
APA, Harvard, Vancouver, ISO, and other styles
8

Werynska, Karolina, and Paola Atzei. "ON-PATENT DRUG REPURPOSING – FUNDER’S PERSPECTIVE." In International Drug Repurposing Conference. ScienceOpen, 2024. http://dx.doi.org/10.14293/idr.23.003kw.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lungu, Andrei. "Some features of cultivation of the actinobacterium saccharopolyspora spinosa." In 5th International Scientific Conference on Microbial Biotechnology. Institute of Microbiology and Biotechnology, Republic of Moldova, 2022. http://dx.doi.org/10.52757/imb22.22.

Full text
Abstract:
Purpose: Actinobacteria (actinomycetes) are in the center of attention because these bacteria produce a variety of natural drugs and other biologically active metabolites, including: antibiotics, enzymes, inhibitors. More than 22,000 biologically active secondary metabolites (including antibiotics) produced by microorganisms have been identified and published in the literature and patented. About half of these compounds are produced by actinomycetes. Currently, about 160 antibiotics are used in medicine and agriculture, 100-120 of these compounds, including streptomycin, erythromycin, gentamic
APA, Harvard, Vancouver, ISO, and other styles
10

Kamijo, Koichi, Yaeko Mitsumori, Hiroshi Kato, and Akiko Kato. "Drug Approval Prediction using Patents." In 2023 Portland International Conference on Management of Engineering and Technology (PICMET). IEEE, 2023. http://dx.doi.org/10.23919/picmet59654.2023.10216836.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Patented drugs"

1

Cockburn, Iain, Jean Lanjouw, and Mark Schankerman. Patents and the Global Diffusion of New Drugs. National Bureau of Economic Research, 2014. http://dx.doi.org/10.3386/w20492.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

MSF Access, Campaign. DR-TB drugs under the microscope 2022. Doctors Without Borders/Médecins Sans Frontières, 2022. http://dx.doi.org/10.57740/zxbm-0414.

Full text
Abstract:
TB was the leading cause of death from a single infectious agent until the COVID pandemic. The number of people newly diagnosed with TB in 2020 fell by 18% from the previous year due to disruptions to health systems and services caused by the pandemic, with only a partial recovery in 2021. As a result, in 2021, only one in three people with drug-resistant TB (DR-TB) received treatment for the disease. However, since the onset of the pandemic, more effective and patient-friendly treatments and regimens for adults and children have become available to the TB community. Now more than ever there i
APA, Harvard, Vancouver, ISO, and other styles
3

ศุภกาญจนกันติ, ศิริเพ็ญ, та พิรัส ประดิษฐวณิช. การวิเคราะห์ทางเศรษฐศาสตร์ต่อการจัดลำดับความสำคัญในชนิดของเภสัชภัณฑ์ที่ทำการวิจัยในประเทศไทย : รายงานวิจัย. จุฬาลงกรณ์มหาวิทยาลัย, 2008. https://doi.org/10.58837/chula.res.2008.69.

Full text
Abstract:
การศึกษานี้มีวัตถุประสงค์เพื่อวิเคราะห์การคัดเลือกและจัดลำดับความสำคัญของเภสัชภัณฑ์ต่อระบบเศรษฐกิจ ตลอดจนวิเคราะห์สภาวการณ์ด้านการตลาด และด้านเศรษฐศาสตร์อื่นๆที่เกี่ยวข้องกับเภสัชภัณฑ์ด้านการแพทย์และ สาธารณสุขของไทยตั้งแต่ปี พ.ศ.2539 จนถึงปี พ.ศ.2545 และศึกษาถึงผลประโยชน์ที่จะได้รับทั้งทางตรงและทางอ้อม ในทางการเงินและเศรษฐกิจจากการพัฒนาเภสัชภัณฑ์ โดยทำการศึกษาเฉพาะในผลิตภัณฑ์ยา ผลการศึกษาศักยภาพในการแข่งขันในกลุ่มผลิตภัณฑ์ยารักษาหรือป้องกันโรคของประเทศไทย พบว่า ประเทศไทย มีความได้เปรียบโดยเปรียบเทียบที่ต่ำ และยังพบว่า อุตสาหกรรมการผลิตยารักษาโรคของประเทศไทยเป็นภาคอุตสาหกรรม ประเภท Final primar
APA, Harvard, Vancouver, ISO, and other styles
4

Galasso, Alberto, and Mark Schankerman. Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool. National Bureau of Economic Research, 2021. http://dx.doi.org/10.3386/w28545.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lanjouw, Jean. Patents, Price Controls, and Access to New Drugs: How Policy Affects Global Market Entry. National Bureau of Economic Research, 2005. http://dx.doi.org/10.3386/w11321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mucke, Hermann. D6.5 Generic guideline for conducting an extended FtO analysis and FtO analyses for all intended clinical trials. REPO4EU, 2023. http://dx.doi.org/10.58647/repo4eu.202300d6.5.

Full text
Abstract:
This document provides the generic methodology and specific resource access points to conduct a freedom-to-operate (FtO) analysis tailored to the needs of a drug repurposing project. It has been compiled based on the extensive experience the author has accumulated with many projects of this type. Its most valuable feature is that it can be executed with minimal technical resources (only web access is required) and can be conducted internally up to the point where potentially critical findings (if any) are discussed with a patent attorney. When conducted properly this method actually improves t
APA, Harvard, Vancouver, ISO, and other styles
7

Conti, Rena, and Ernst Berndt. Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007. National Bureau of Economic Research, 2014. http://dx.doi.org/10.3386/w20016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Drake, Keith, and Thomas McGuire. Most-Favored Entry Clauses in Drug Patent Litigation Settlements as a Potential Reverse Payment. National Bureau of Economic Research, 2022. http://dx.doi.org/10.3386/w29801.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Drake, Keith, and Thomas McGuire. Using Stock Price Movements to Estimate the Harm from Anticompetitive Drug Patent Litigation Settlements. National Bureau of Economic Research, 2024. http://dx.doi.org/10.3386/w33196.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Saha, Amrita, Juan Manuel Del Pozo Segura, and Gabriel Palazzo. Firm-Level Innovation and the Role of Political Capabilities: Evidence for the Pharmaceuticals Industry. Institute of Development Studies, 2025. https://doi.org/10.19088/ids.2025.036.

Full text
Abstract:
The global debate on balancing incentives for innovation in the pharmaceutical industry and facilitating competition for greater access to affordable medicines and vaccines has intensified in the aftermath of the Covid-19 pandemic. Drug discovery and vaccine development are expensive processes involving significant research and development (R&amp;D) costs. And while the economic fundamentals of incentivising innovation for the pharmaceutical industry are traditionally linked to patenting, several scholars have highlighted the inefficiencies and greater appropriation of the returns from R&amp;D
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Patented drugs' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography